EUVIMEDEUVIMED entdecken
Crossref

CDC25A Alleviates Obstructive Sleep Apnea‐Hypopnea Syndrome With Hypertension and Inhibits Ferroptosis

Xin Yang, Chunsheng Wang, Deng Ouyang, Haofeng Xu, Zhile Wu, HuiLing Ye, Ping Yan iD

Journal of Sleep Research · 2026

DOI: 10.1111/jsr.70155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Sleep Research, 2026. Verfasst von Xin Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou City, Guangdong Province, China. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Ferroptosis, Hypertension, cdc25 Phosphatases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: Guangzhou Municipal Health Science and Technology Project, Medical Research Fund of Guangdong Provinc, Guangzhou Basic Research Program Co-funded by Municipal Schools (lnstitutes) by Guangzhou Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obstructive sleep apnea‐hypopnea syndrome (OSAHS) is significantly correlated with hypertension. This investigation aimed to explore the effect of ferroptosis on OSAHS‐hypertension. Ferroptosis‐associated genes were screened based on the GSE205050 dataset and FerrDb database. An OSAHS‐hypertension model was established by exposing Sprague Dawley rats to chronic intermittent hypoxia for 8 weeks, and human umbilical vein endothelial cells (HUVECs) were exposed to intermittent hypoxia in vitro. CDC25A was overexpressed using recombinant adeno‐associated virus in vivo and plasmid transfection in vitro. Ferroptosis markers, oxidative stress indicators, blood pressure, abdominal aortic tissue histopathology, and endothelial cell viability/apoptosis were then assessed. Six ferroptosis‐associated hub genes were identified, including CDC25A, EZH2, PARP1, HELLS, FANCD2, and RRM2, all of which were lowly expressed. In the rat model of OSAHS‐hypertension, overexpression of CDC25A significantly reduced systolic and diastolic blood pressure as well as vascular wall thickness, while increasing α‐SMA expression. Biochemical analyses showed that CDC25A decreased malondialdehyde (MDA) and Fe 2+ levels while increasing glutathione (GSH), superoxide dismutase (SOD), and ferroptosis‐associated proteins (FTH1, SLC7A11, GPX4). CDC25A overexpression in HUVECs ameliorated hypoxia‐induced endothelial dysfunction by inhibiting ferroptosis and apoptosis and promoting cell survival; however, these protective effects were significantly abrogated by co‐treatment with erastin. CDC25A inhibits OSAHS‐hypertension progression and modulates ferroptosis‐related pathways. This study identifies ferroptosis as a potential therapeutic target in OSAHS‐associated hypertension, with CDC25A acting as a key regulatory factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveFerroptosisHypertensioncdc25 PhosphatasesAnimalsRats, Sprague-DawleyRatsHumansHuman Umbilical Vein Endothelial CellsMaleOxidative StressDisease Models, Animal

Stichwörter der Autor:innen

CDC25Achronic intermittent hypoxiaferroptosisobstructive sleep apnea‐hypopnea syndrome with hypertension

Substanzen

cdc25 Phosphatases

Autor:innen und Institutionen

  • Department of General Practice, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou City, Guangdong Province, China.
  • Department of Neurology, The Second People's Hospital of Baiyun Guangzhou, Guangzhou City, Guangdong Province, China.
  • Department of Geriatrics, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou City, Guangdong Province, China.

ORCID-Profile: Ping Yan

Förderung

  • Guangzhou Municipal Health Science and Technology Project
  • Medical Research Fund of Guangdong Provinc
  • Guangzhou Basic Research Program Co-funded by Municipal Schools (lnstitutes) by Guangzhou Science and Technology Bureau

Zitieren

APA

Yang, X., Wang, C., Ouyang, D., Xu, H., Wu, Z., Ye, H., & Yan, P. (2026). CDC25A Alleviates Obstructive Sleep Apnea‐Hypopnea Syndrome With Hypertension and Inhibits Ferroptosis. Journal of Sleep Research. https://doi.org/10.1111/jsr.70155

Vancouver

Yang X, Wang C, Ouyang D, Xu H, Wu Z, Ye H, et al. CDC25A Alleviates Obstructive Sleep Apnea‐Hypopnea Syndrome With Hypertension and Inhibits Ferroptosis. Journal of Sleep Research. 2026. doi:10.1111/jsr.70155

BibTeX
@article{Yang2026,
  author = {Yang, Xin and Wang, Chunsheng and Ouyang, Deng and Xu, Haofeng and Wu, Zhile and Ye, HuiLing and Yan, Ping},
  title = {CDC25A Alleviates Obstructive Sleep Apnea‐Hypopnea Syndrome With Hypertension and Inhibits Ferroptosis},
  journal = {Journal of Sleep Research},
  year = {2026},
  doi = {10.1111/jsr.70155}
}
Kostenlos starten →